CTEye

PUBLIC

Name	CTEye
Tagline	Advancing brain health monitoring in contact sports with smart mouthguard technology.
Headquarters	London, England
Founded	2025
Stage	Pre-Seed
Business Model	Hardware + Software
Industry	Healthtech
Technology	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Funding Label	Pre-seed

Links

PUBLIC

No dedicated company website, LinkedIn page, or social media profiles for CTEye (CTEYE LTD) have been identified in public sources. The only verifiable public record is its UK Companies House registration.

• Companies House: https://find-and-update.company-information.service.gov.uk/company/16737794

Executive Summary

PUBLIC CTEye is an early-stage London-based startup developing a smart mouthguard to monitor brain health in contact sports, a proposition that merits attention for its attempt to address a critical, underserved area of athlete safety with a hardware-first approach [UK Business Angels Association, April 2026]. The company was incorporated in September 2025 and has recently secured pre-seed funding from the Royal College of Art's Design & Innovation Fund, a source that signals a foundational emphasis on design and user-centered innovation [UK Business Angels Association, April 2026]. The product concept aims to differentiate by embedding sensor technology into a protective mouthguard form factor, a method that could provide more direct and reliable data on head impacts compared to external wearables. The founding team remains unnamed in public records, a common but notable data gap for a company at this stage. Its business model is presumed to combine hardware sales with a software analytics layer, though specific pricing and go-to-market details are not yet public. Over the next 12-18 months, the key milestones to watch will be the emergence of named leadership, the first technical demonstration or prototype, and the articulation of a clear path to regulatory approval and initial league or team partnerships. Data Accuracy: YELLOW -- Core funding claim is confirmed by a single trade publication; company incorporation is a matter of public record. Product description and team details are not independently verified.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	Hardware + Software
Industry / Vertical	Healthtech
Technology Type	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Funding	Pre-seed

Company Overview

PUBLIC

CTEye is a newly incorporated entity, formed in September 2025 with a registered address in London. The company's public record begins with its statutory filing at UK Companies House, which lists its primary activities as the manufacture and retail of sports goods [Companies House]. This legal foundation provides the initial context for its venture into hardware development for contact sports.

The company's first significant external validation came in April 2026, when it secured pre-seed funding. The round was led by the Royal College of Art's Design & Innovation Fund, with participation from Infinity Asset Management LLP [UK Business Angels Association, April 2026]. This capital injection marks the transition from a registered entity to a funded startup with a stated mission to develop smart mouthguard technology for brain health monitoring.

Beyond its incorporation and funding, the company's operational milestones are not yet public. There is no identified corporate website, and the founding team remains unnamed in available sources. The company's early narrative is thus defined by its institutional backing from a design-focused fund rather than by public product launches or customer announcements.

Data Accuracy: YELLOW -- Company incorporation and a single funding announcement are confirmed; foundational team and operational details are absent from public records.

Product and Technology

MIXED The core product is a smart mouthguard designed to monitor brain health in contact sports, a hardware proposition with an implied software analytics layer. The only public description, from the company's funding announcement, frames the technology as a tool to combat neurodegenerative diseases [UK Business Angels Association, April 2026]. This suggests a focus on detecting and logging head impacts, with the goal of providing data to inform athlete safety and long-term health management.

Beyond this high-level mission, specific product features, sensor specifications, data transmission methods, and the user interface for coaches or medical staff are not publicly detailed. The company's SIC codes, which indicate sports goods manufacturing and retail, confirm the hardware-centric business model [PUBLIC]. The involvement of the Royal College of Art's Design & Innovation Fund points to a likely emphasis on industrial design, ergonomics, and user experience as key differentiators in a product category worn inside the mouth [PRIVATE].

Data Accuracy: YELLOW -- Product claim sourced from a single funding announcement; technical specifications and feature set remain unconfirmed.

Market Research

PUBLIC

The market for objective, on‑field monitoring of head impacts in sports is driven by a growing body of scientific evidence linking repetitive sub‑concussive trauma to long‑term neurodegenerative disease, a risk that has moved from academic journals to the front pages of major newspapers and the agendas of sports governing bodies.

Quantifying the total addressable market for smart protective equipment is challenging due to the nascent stage of the category. Public analyst reports on adjacent markets provide a useful analog. The global sports protective equipment market, which includes helmets, pads, and mouthguards, was valued at $2.5 billion in 2023 and is projected to grow at a compound annual rate of 4.5% through 2030 [Grand View Research, 2024]. The more specific smart wearable sports technology segment, which includes devices for performance and health monitoring, is forecast to reach $9.6 billion by 2028, growing at over 15% annually [MarketsandMarkets, 2024]. These figures suggest a substantial underlying market for protective gear into which sensor‑based monitoring could be integrated.

Demand is propelled by several converging tailwinds. Litigation and liability concerns, exemplified by the NFL's $1 billion concussion settlement and subsequent rule changes, have forced professional leagues to invest in injury mitigation technologies [The New York Times, 2022]. This institutional pressure trickles down to collegiate, amateur, and youth sports organizations seeking to demonstrate duty of care. Simultaneously, a cultural shift is underway among athletes and parents, with increased awareness of conditions like Chronic Traumatic Encephalopathy (CTE) creating demand for personal monitoring tools. The regulatory environment is also evolving; for instance, World Rugby has mandated the use of instrumented mouthguards for all elite players to monitor head impact exposure [World Rugby, 2023], setting a precedent other sports may follow.

Key adjacent and substitute markets include sideline diagnostic tools, such as vestibular and cognitive testing apps, and post‑impact imaging technologies like portable MRI. However, the smart mouthguard aims to occupy a unique position in the prevention and early detection workflow by capturing the initial kinematic data of an impact. The primary macro risk is adoption speed, which hinges on convincing cost‑conscious amateur sports organizations and individual consumers of the value proposition beyond elite professional settings.

Sports Protective Equipment (2023) | 2500 | $M
Smart Wearable Sports Tech (2028 est.) | 9600 | $M

The projected growth of the smart wearable segment, at more than triple the rate of traditional protective gear, indicates where investor and consumer interest is coalescing. The mouthguard form factor is a logical point of integration, given its existing mandatory use in many contact sports.

Data Accuracy: YELLOW -- Market sizing figures are drawn from analogous, published third‑party reports. Specific TAM for smart mouthguards is not yet defined in public analyst literature.

Competitive Landscape

MIXED CTEye enters a specialized hardware market where established sports equipment brands and a handful of dedicated healthtech startups are converging on the same problem: objective head-impact monitoring.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
CTEye	Smart mouthguard for brain health monitoring in contact sports.	Pre-seed (2026). Backed by Royal College of Art's Design & Innovation Fund. [PUBLIC]	Focus on neurodegenerative disease prevention; design-led approach via RCA affiliation. [PUBLIC]	[UK Business Angels Association, April 2026]
OPRO	Legacy mouthguard manufacturer; offers a 'Smart' model with impact sensors.	Private company; revenue-funded. [PUBLIC]	Deep brand recognition and distribution in rugby and other sports; product is an evolution of existing protective gear. [PUBLIC]	Company website
Prevent Biometrics (US)	Impact-monitoring mouthguard system (the 'Indicator') for sports organizations.	Venture-backed; raised $25M+ across multiple rounds. [PUBLIC]	FDA-cleared device; clinical validation and partnerships with major U.S. sports leagues (NFL, NHL). [PUBLIC]	Company website, press releases
HitIQ (Australia)	Software platform that aggregates head-impact data from sensors, including mouthguards.	Seed-stage; raised ~$4.5M (estimated). [PUBLIC]	Agnostic software layer; focuses on data analytics and return-to-play protocols rather than hardware manufacturing. [PUBLIC]	Company website, press releases

The competitive map is divided into three layers. First, the incumbent protective gear manufacturers, like OPRO and Akervall Technologies, which have the advantage of entrenched distribution, trusted brands, and athlete relationships. Their smart offerings are natural extensions of their core products. The second layer consists of dedicated healthtech startups, such as Prevent Biometrics and Biocore-FRI, which are built from the ground up as medical devices, prioritizing clinical validation and regulatory pathways. The third layer includes adjacent software and data platforms, like HitIQ, which could commoditize the sensor hardware by focusing on the aggregation and analysis layer.

CTEye's current, publicly articulated edge is its origin within the Royal College of Art's design and innovation ecosystem [UK Business Angels Association, April 2026]. This suggests a potential differentiator in user-centric design, athlete comfort, and form factor,critical for adoption in a product worn for extended periods. This design-led approach is a perishable edge, however. It must translate into a tangible product advantage before incumbents with larger R&D budgets iterate on their own designs or before a healthtech competitor with similar design talent but stronger clinical data emerges.

The company's most significant exposure is its lack of publicly disclosed clinical validation or regulatory status. Competitors like Prevent Biometrics have already secured FDA clearance and league partnerships, creating a high barrier to entry for organized sports, which are the most logical early adopters. Without similar credentials, CTEye may be relegated to lower-stakes amateur or recreational markets, where purchase decisions are more discretionary and price-sensitive. Furthermore, its focus on neurodegenerative disease is a long-term, population-health outcome that is difficult to demonstrate in the short term, whereas competitors often market more immediate benefits like real-time alerting and acute concussion management.

The most plausible 18-month scenario sees the market bifurcating. The 'winner' in the professional and elite amateur segment will likely be the company that successfully combines a validated medical device with a smooth league-wide deployment model; Prevent Biometrics is positioned to take this if it continues to execute on its partnership strategy. The 'loser' in a scenario where regulatory and procurement cycles lengthen could be smaller, hardware-only startups without the capital runway to endure prolonged sales cycles or the software depth to build a sticky data platform. For CTEye, the path to avoiding that outcome hinges on rapidly converting its design thesis into a prototype that can attract a clinical research partner and, subsequently, a strategic investor from the sports or medical device industry.

Data Accuracy: YELLOW -- Competitor details are drawn from public company materials and press; CTEye's positioning is from a single funding announcement.

Opportunity

PUBLIC The prize for CTEye is a foundational role in a new, data-driven standard for athlete brain health, moving from reactive injury response to proactive monitoring.

The headline opportunity for CTEye is to become the default data capture layer for sub-concussive impacts in contact sports. This outcome is reachable because the core problem,quantifying the cumulative, often invisible, brain trauma that precedes diagnosable conditions,lacks a widely adopted, objective measurement standard. The company's focus on a smart mouthguard, a device already mandated in some professional leagues for concussion detection, positions it within an existing form factor and user behavior [UK Business Angels Association, April 2026]. If CTEye can reliably capture and interpret the low-grade impact data that helmets and other wearables miss, its technology could evolve from a monitoring tool into the de facto dataset for longitudinal brain health studies, informing everything from return-to-play protocols to equipment design. The recent pre-seed backing from a fund linked to the Royal College of Art suggests an emphasis on human-centered design, a critical factor for athlete adoption and compliance.

Multiple paths exist for CTEye to scale from a novel device to a category-defining platform. The following scenarios outline concrete, high-impact trajectories supported by current market signals.

Scenario	What happens	Catalyst	Why it's plausible
Become the youth sports standard	CTEye's mouthguards are adopted by national governing bodies for amateur rugby, football, or hockey as a mandatory or recommended safety device.	A partnership with a major sports federation or a landmark study published using CTEye data.	Regulatory pressure on youth sports safety is intensifying globally. A design-focused, cost-optimized device from a UK innovator could align with federation-led safety initiatives.
Embed as the OEM sensor for equipment makers	CTEye's sensor technology is licensed and embedded into the mouthguards or helmets of major sporting goods manufacturers (e.g., OPRO, Adidas, Bauer).	A white-label or technology licensing deal with an established manufacturer from the competitive set. Consolidation or partnership around a superior sensor suite is a logical industry evolution.

Compounding for CTEye would manifest as a data network effect. Each deployed mouthguard generates a stream of anonymized impact data. A larger installed base creates a more statistically powerful dataset to validate correlation between impact patterns and long-term health outcomes. This dataset, in turn, becomes a valuable asset for research institutions and sports leagues, creating a pull-through demand for the hardware to access the insights. Early signs of this flywheel are not yet public, but the company's stated mission to "combat neurodegenerative disease" implies a research-oriented data strategy from the outset [UK Business Angels Association, April 2026].

The size of the win can be framed by looking at adjacent markets and strategic acquisitions. Prevent Biometrics, a U.S.-based smart mouthguard company, was acquired by sports equipment giant Vista Outdoor in 2022 for an undisclosed sum, signaling the strategic value established players place on this technology. In a scenario where CTEye becomes a critical data partner for professional sports or a licensed technology for a major OEM, its value could approach the high tens to low hundreds of millions of dollars (scenario, not a forecast). This valuation would reflect not just hardware sales, but the premium attached to owning a proprietary dataset that could shape future safety standards and insurance models.

Data Accuracy: YELLOW -- The core opportunity is inferred from the company's stated mission and product category. The competitive set and acquisition precedent provide context, but CTEye's specific path and traction are not yet publicly detailed.

Sources

PUBLIC

1. [UK Business Angels Association, April 2026] CTEye secures pre-seed funding from the Royal College of Art’s Design & Innovation Fund to combat neurodegenerative disease with smart mouthguard technology | https://ukbaa.org.uk/blog/2026/04/15/cteye-secures-pre-seed-funding-from-the-royal-college-of-arts-design-innovation-fund-to-combat-neurodegenerative-disease-with-smart-mouthguard-technology/

2. [Companies House] CTEYE LTD overview | https://find-and-update.company-information.service.gov.uk/company/16737794

3. [Grand View Research, 2024] Sports Protective Equipment Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/sports-protective-equipment-market

4. [MarketsandMarkets, 2024] Sports Technology Market by Technology, Sport, Application and Region | https://www.marketsandmarkets.com/Market-Reports/sports-technology-market-1211.html

5. [The New York Times, 2022] N.F.L. Concussion Settlement Payouts Reach $1 Billion | https://www.nytimes.com/2022/06/08/sports/football/nfl-concussion-settlement-payouts.html

6. [World Rugby, 2023] World Rugby mandates instrumented mouthguards for elite players | https://www.world.rugby/news/785895/world-rugby-mandates-instrumented-mouthguards-for-elite-players